Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:51 UTC
Update Date2022-03-07 02:51:53 UTC
HMDB IDHMDB0015168
Secondary Accession Numbers
  • HMDB15168
Metabolite Identification
Common NameCerulenin
DescriptionCerulenin belongs to the class of organic compounds known as oxirane carboxylic acids and derivatives. Oxirane carboxylic acids and derivatives are compounds containing an oxirane ring bearing a carboxylic acid group (or a derivative thereof). At an intraperitoneal dose of 30 milligrams per kilogram, it has been shown to inhibit feeding and induce dramatic weight loss in mice by a mechanism similar to, but independent or downstream of, leptin signaling. Cerulenin is a drug which is used for use as a biochemical tool, cerulenin is shown to cause dramatic weight loss in animals. Cerulenin is an antifungal antibiotic that inhibits fatty acid and steroid biosynthesis. Cerulenin is an extremely weak basic (essentially neutral) compound (based on its pKa). Cerulenin is a potentially toxic compound. Inhibition involves covalent thioacylation that permanently inactivates the enzymes. These two behaviors may increase the availability of energy in the form of ATP, perhaps sensed by AMPK, in the hypothalamus. It is found naturally in the industrial strain Cephalosporium caerulens (Sarocladium oryzae, the sheath rot pathogen of rice). In sterol synthesis, cerulenin inhibits HMG-CoA synthetase activity. But in general conclusion, cerulenin has inhibitory effects on sterol synthesis. It also has the related activity of stimulating fatty acid oxidation through the activation of CPT1, another enzyme normally inhibited by malonyl-CoA. Cerulenin causes a dose-dependent decrease in HER2/neu protein levels in breast cancer cells, from 14% at 1.25 to 78% at 10 milligrams per liter, and targeting of fatty acid synthase by related drugs has been suggested as a possible treatment. In fatty acid synthesis, it has been reported to bind in equimolar ratio to b-keto-acyl-ACP synthase, one of the seven moieties of fatty acid synthase, blocking the interaction of malonyl-CoA. It was also reported that cerulenin specifically inhibited fatty acid biosynthesis in Saccharomyces cerevisiae without having an effect on sterol formation.
Structure
Data?1582753266
Synonyms
ValueSource
(2R,3S)-3-(Nona-4,7-dienoyl)oxirane-2-carboximidateHMDB
Chemical FormulaC12H17NO3
Average Molecular Weight223.2683
Monoisotopic Molecular Weight223.120843415
IUPAC Name(2R,3S)-3-(nona-4,7-dienoyl)oxirane-2-carboxamide
Traditional Namecerulenin
CAS Registry Number17397-89-6
SMILES
CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(N)=O
InChI Identifier
InChI=1S/C12H17NO3/c1-2-3-4-5-6-7-8-9(14)10-11(16-10)12(13)15/h2-3,5-6,10-11H,4,7-8H2,1H3,(H2,13,15)/t10-,11-/m1/s1
InChI KeyGVEZIHKRYBHEFX-GHMZBOCLSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as oxirane carboxylic acids and derivatives. Oxirane carboxylic acids and derivatives are compounds containing an oxirane ring bearing a carboxylic acid group (or a derivative thereof).
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassEpoxides
Sub ClassOxirane carboxylic acids and derivatives
Direct ParentOxirane carboxylic acids and derivatives
Alternative Parents
Substituents
  • Oxirane carboxylic acid or derivatives
  • Monosaccharide
  • Carboxamide group
  • Ketone
  • Primary carboxylic acid amide
  • Carboxylic acid derivative
  • Dialkyl ether
  • Ether
  • Oxacycle
  • Carbonyl group
  • Organonitrogen compound
  • Organooxygen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Organic nitrogen compound
  • Aliphatic heteromonocyclic compound
Molecular FrameworkAliphatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
Role
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting Point93.5 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility1.6 g/LNot Available
LogP1.2Not Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility1.6 g/LALOGPS
logP1.38ALOGPS
logP1.5ChemAxon
logS-2.1ALOGPS
pKa (Strongest Acidic)14.16ChemAxon
pKa (Strongest Basic)-4.3ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area72.69 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity62.54 m³·mol⁻¹ChemAxon
Polarizability23.9 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+157.87331661259
DarkChem[M-H]-156.45931661259
DeepCCS[M+H]+153.46430932474
DeepCCS[M-H]-151.10630932474
DeepCCS[M-2H]-184.58630932474
DeepCCS[M+Na]+160.17330932474
AllCCS[M+H]+155.332859911
AllCCS[M+H-H2O]+151.632859911
AllCCS[M+NH4]+158.832859911
AllCCS[M+Na]+159.832859911
AllCCS[M-H]-155.432859911
AllCCS[M+Na-2H]-156.032859911
AllCCS[M+HCOO]-156.832859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.4.48 minutes32390414
Predicted by Siyang on May 30, 202212.4667 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20221.55 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid26.0 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid2178.0 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid305.8 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid136.1 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid208.9 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid138.1 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid441.1 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid392.1 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)108.3 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid1110.6 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid416.9 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1078.1 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid322.2 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid356.8 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate361.6 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA218.6 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water7.8 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
CeruleninCC=CCC=CCCC(=O)[C@H]1O[C@H]1C(N)=O2841.7Standard polar33892256
CeruleninCC=CCC=CCCC(=O)[C@H]1O[C@H]1C(N)=O1794.5Standard non polar33892256
CeruleninCC=CCC=CCCC(=O)[C@H]1O[C@H]1C(N)=O1956.1Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Cerulenin,1TMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C)=C1O[C@H]1C(N)=O1923.7Semi standard non polar33892256
Cerulenin,1TMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C)=C1O[C@H]1C(N)=O1835.2Standard non polar33892256
Cerulenin,1TMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C)=C1O[C@H]1C(N)=O2847.3Standard polar33892256
Cerulenin,1TMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C)[C@H]1O[C@H]1C(N)=O1946.4Semi standard non polar33892256
Cerulenin,1TMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C)[C@H]1O[C@H]1C(N)=O1767.1Standard non polar33892256
Cerulenin,1TMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C)[C@H]1O[C@H]1C(N)=O2860.6Standard polar33892256
Cerulenin,1TMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C1874.0Semi standard non polar33892256
Cerulenin,1TMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C1886.5Standard non polar33892256
Cerulenin,1TMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C2553.9Standard polar33892256
Cerulenin,2TMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C)=C1O[C@H]1C(=O)N[Si](C)(C)C1955.6Semi standard non polar33892256
Cerulenin,2TMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C)=C1O[C@H]1C(=O)N[Si](C)(C)C2022.9Standard non polar33892256
Cerulenin,2TMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C)=C1O[C@H]1C(=O)N[Si](C)(C)C2363.5Standard polar33892256
Cerulenin,2TMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C2002.0Semi standard non polar33892256
Cerulenin,2TMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C1992.4Standard non polar33892256
Cerulenin,2TMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C2417.1Standard polar33892256
Cerulenin,2TMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C)[Si](C)(C)C2006.2Semi standard non polar33892256
Cerulenin,2TMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C)[Si](C)(C)C2066.1Standard non polar33892256
Cerulenin,2TMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C)[Si](C)(C)C2318.7Standard polar33892256
Cerulenin,3TMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C)=C1O[C@H]1C(=O)N([Si](C)(C)C)[Si](C)(C)C2058.0Semi standard non polar33892256
Cerulenin,3TMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C)=C1O[C@H]1C(=O)N([Si](C)(C)C)[Si](C)(C)C2138.5Standard non polar33892256
Cerulenin,3TMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C)=C1O[C@H]1C(=O)N([Si](C)(C)C)[Si](C)(C)C2164.2Standard polar33892256
Cerulenin,3TMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C)[Si](C)(C)C2096.7Semi standard non polar33892256
Cerulenin,3TMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C)[Si](C)(C)C2142.4Standard non polar33892256
Cerulenin,3TMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C)[Si](C)(C)C2227.3Standard polar33892256
Cerulenin,1TBDMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C(C)(C)C)=C1O[C@H]1C(N)=O2166.3Semi standard non polar33892256
Cerulenin,1TBDMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C(C)(C)C)=C1O[C@H]1C(N)=O2042.9Standard non polar33892256
Cerulenin,1TBDMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C(C)(C)C)=C1O[C@H]1C(N)=O2905.4Standard polar33892256
Cerulenin,1TBDMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C(C)(C)C)[C@H]1O[C@H]1C(N)=O2184.3Semi standard non polar33892256
Cerulenin,1TBDMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C(C)(C)C)[C@H]1O[C@H]1C(N)=O1958.6Standard non polar33892256
Cerulenin,1TBDMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C(C)(C)C)[C@H]1O[C@H]1C(N)=O2919.1Standard polar33892256
Cerulenin,1TBDMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C(C)(C)C2092.9Semi standard non polar33892256
Cerulenin,1TBDMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C(C)(C)C2101.5Standard non polar33892256
Cerulenin,1TBDMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C(C)(C)C2587.9Standard polar33892256
Cerulenin,2TBDMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C(C)(C)C)=C1O[C@H]1C(=O)N[Si](C)(C)C(C)(C)C2392.0Semi standard non polar33892256
Cerulenin,2TBDMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C(C)(C)C)=C1O[C@H]1C(=O)N[Si](C)(C)C(C)(C)C2393.2Standard non polar33892256
Cerulenin,2TBDMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C(C)(C)C)=C1O[C@H]1C(=O)N[Si](C)(C)C(C)(C)C2517.7Standard polar33892256
Cerulenin,2TBDMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C(C)(C)C)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C(C)(C)C2435.3Semi standard non polar33892256
Cerulenin,2TBDMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C(C)(C)C)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C(C)(C)C2346.6Standard non polar33892256
Cerulenin,2TBDMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C(C)(C)C)[C@H]1O[C@H]1C(=O)N[Si](C)(C)C(C)(C)C2553.3Standard polar33892256
Cerulenin,2TBDMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2439.2Semi standard non polar33892256
Cerulenin,2TBDMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2464.9Standard non polar33892256
Cerulenin,2TBDMS,isomer #3CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2435.2Standard polar33892256
Cerulenin,3TBDMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C(C)(C)C)=C1O[C@H]1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2700.4Semi standard non polar33892256
Cerulenin,3TBDMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C(C)(C)C)=C1O[C@H]1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2639.1Standard non polar33892256
Cerulenin,3TBDMS,isomer #1CC=CCC=CCCC(O[Si](C)(C)C(C)(C)C)=C1O[C@H]1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2400.1Standard polar33892256
Cerulenin,3TBDMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C(C)(C)C)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2734.5Semi standard non polar33892256
Cerulenin,3TBDMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C(C)(C)C)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2676.0Standard non polar33892256
Cerulenin,3TBDMS,isomer #2CC=CCC=CCC=C(O[Si](C)(C)C(C)(C)C)[C@H]1O[C@H]1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2419.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Cerulenin GC-MS (Non-derivatized) - 70eV, Positivesplash10-06rf-9600000000-ac88ca6a297eb89d73b42017-08-28Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Cerulenin GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 10V, Positive-QTOFsplash10-05fr-1290000000-202e41a2408ad9df3f622017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 20V, Positive-QTOFsplash10-0a4r-8950000000-c0265c2ede42a8a7b9442017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 40V, Positive-QTOFsplash10-0frf-9100000000-c8d70361d98f08b9775a2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 10V, Negative-QTOFsplash10-00di-4490000000-130e0abcad17614007d82017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 20V, Negative-QTOFsplash10-0570-9830000000-b6afbfbbfa11b458c4ba2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 40V, Negative-QTOFsplash10-0006-9000000000-289b3846b10b0578e10f2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 10V, Positive-QTOFsplash10-05fr-6970000000-a192a4a992558941f3f02021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 20V, Positive-QTOFsplash10-014i-9400000000-f684bf91e79510c00ed82021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 40V, Positive-QTOFsplash10-014i-9200000000-91ff9f0cebc2d5a63e302021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 10V, Negative-QTOFsplash10-00dl-6290000000-dc435b26c818bc2f01342021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 20V, Negative-QTOFsplash10-0006-9100000000-ac3aa58779f68cf0a7992021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Cerulenin 40V, Negative-QTOFsplash10-0006-9000000000-79c001be721cdc21c3742021-10-11Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Cytoplasm
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB01034 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB01034 details
Abnormal Concentrations
Not Available
Predicted Concentrations
BiospecimenValueOriginal ageOriginal sexOriginal conditionComments
Blood0.000 uMAdult (>18 years old)BothNormalPredicted based on drug qualities
Blood0.000 umol/mmol creatinineAdult (>18 years old)BothNormalPredicted based on drug qualities
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB01034
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID4445281
KEGG Compound IDC12058
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkCerulenin
METLIN IDNot Available
PubChem Compound5282054
PDB IDNot Available
ChEBI ID171741
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Straub SG, Yajima H, Komatsu M, Aizawa T, Sharp GW: The effects of cerulenin, an inhibitor of protein acylation, on the two phases of glucose-stimulated insulin secretion. Diabetes. 2002 Feb;51 Suppl 1:S91-5. [PubMed:11815464 ]
  2. Huang P, Zhu S, Lu S, Dai Z, Jin Y: [An experimental study on cerulenin induced apoptosis of human colonic cancer cells]. Zhonghua Bing Li Xue Za Zhi. 2000 Apr;29(2):115-8. [PubMed:11866903 ]

Enzymes

General function:
Involved in transferase activity
Specific function:
Fatty acid synthetase catalyzes the formation of long-chain fatty acids from acetyl-CoA, malonyl-CoA and NADPH. This multifunctional protein has 7 catalytic activities and an acyl carrier protein.
Gene Name:
FASN
Uniprot ID:
P49327
Molecular weight:
273424.06
References
  1. Oskouian B, Saba JD: YAP1 confers resistance to the fatty acid synthase inhibitor cerulenin through the transporter Flr1p in Saccharomyces cerevisiae. Mol Gen Genet. 1999 Mar;261(2):346-53. [PubMed:10102370 ]
  2. Li JN, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, Han WF, Pizer ES: Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res. 2001 Feb 15;61(4):1493-9. [PubMed:11245456 ]
  3. Heiligtag SJ, Bredehorst R, David KA: Key role of mitochondria in cerulenin-mediated apoptosis. Cell Death Differ. 2002 Sep;9(9):1017-25. [PubMed:12181752 ]
  4. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
  5. Flavin R, Peluso S, Nguyen PL, Loda M: Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol. 2010 Apr;6(4):551-62. doi: 10.2217/fon.10.11. [PubMed:20373869 ]
  6. Lupu R, Menendez JA: Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr Pharm Biotechnol. 2006 Dec;7(6):483-93. [PubMed:17168665 ]
  7. Ronnett GV, Kim EK, Landree LE, Tu Y: Fatty acid metabolism as a target for obesity treatment. Physiol Behav. 2005 May 19;85(1):25-35. [PubMed:15878185 ]